Sagent Pharmaceuticals, Inc. (SGNT) Tops Q1 EPS by 16c
Get Alerts SGNT Hot Sheet
Join SI Premium – FREE
Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) reported Q1 EPS of $0.16, $0.16 better than the analyst estimate of $0.00. Revenue for the quarter came in at $70.9 million versus the consensus estimate of $65.66 million.
For earnings history and earnings-related data on Sagent Pharmaceuticals, Inc. (SGNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Business First Bancshares, Inc. (BFST) Misses Q1 EPS by 7c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!